Search Results 321-330 of 13945 for Moderate acute malnutrition

  1. A Study To Evaluate The Safety And Efficacy Of ABT-494 For Induction And Maintenance Therapy In Subjects With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

    Recent (within past 6 months) cerebrovascular accident, myocardial infarction, coronary stenting or Moderate to severe congestive heart failure (New York Heart ...

  2. Liver biopsy - Mayo Clinic

    Stages or grades are usually mild, moderate or severe. Your healthcare professional will discuss what treatment, if any, you need. Clinical trials. Explore ...

  3. Non-Invasive Monitoring of Potassium Levels in Patients with Congestive Heart Failure - Mayo Clinic

    Acute MI within the month prior to enrollment; Pregnant women. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team ...

  4. Phase IIa Study Evaluating Safety And Efficacy Of BL-8040 In Relapsed/Refractory AML Patients - Mayo Clinic

    The goal of this clinical research study is to learn if BL-8040 in combination with cytarabine (Ara-C) can help to control the disease in patients with Acute ...

  5. Hydrocephalus - Diagnosis and treatment - Mayo Clinic

    Some children might need medicine to help them feel calm, known as mild sedation, but some hospitals use a faster MRI that usually doesn't require it. This ...

  6. Markers of Inflammatory Bowel Disease Severity - Mayo Clinic

    Participation eligibility · Moderate to severely active ulcerative colitis (defined by Ulcerative Colitis Endoscopic Index of Severity (UCEIS) score of ≥2) ...

  7. Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptoms (RECOVER-VITAL) - Mayo Clinic

    Moderate or severe immunocompromised patients, such as those described in the NIH COVID-19 Treatment Guidelines (https://www.covid19treatmentguidelines.nih ...

  8. Risk-Adapted Chemotherapy In Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia - Mayo Clinic

    Risk-Adapted Chemotherapy In Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia ... acute lymphoblastic leukemia. Drugs used ...

  9. LY4268989 (MORF-057) Co-Administered With Mirikizumab In Adults With Moderately To Severely Active Ulcerative Colitis: - Mayo Clinic

    LY4268989 (MORF-057) Co-Administered With Mirikizumab In Adults With Moderately To Severely Active Ulcerative Colitis: · Share · Facebook · Twitter.

  10. A Study To Assess Whether Etrolizumab Is A Safe And Effective Treatment For Participants With Moderately To Severely Active Crohn's Disease (CD) - Mayo Clinic

    History of moderate or severe allergic or anaphylactic/anaphylactoid reactions to chimeric, human, or humanized antibodies, fusion proteins, or murine ...